Ujjivan Financial briefly skimmed the 15% UC of Rs.172 and since then it has only risen further to 175.50, with the 15% UC now standing at Rs.179.85. Since the opening bell, it has remained stable among the three gainers on the BSE.

The company announced its Q4FY20 earnings and the market is thrilled with the numbers. It reported a huge 80% (YoY) jump in consolidate net profit at Rs.77 crore on a 36% rise in income at Rs.805 crore.

The board of directors has proposed a final dividend at the rate of Rs 0. 80 per share (8 per cent) for the FY 2019-20.

The company stated that the extent to which the COVID-19 pandemic will impact the Bank's results will depend of future developments, which are incapable of assessment at this point in time, including among other things, any new information concerning the severity of the COVID-19 pandemic and any action to contain its spread or mitigate its impact whether government-mandated or elected by the Bank.

On the Holding Company, it said there is no material impact of COVID-19 other than the fall in the market value of its investment in USFB.

The Bank said that it is maintaining a liquidity buffer for unforeseen contingencies in the coming months. The surplus is being deployed in reverse repos, term lending and liquid funds. Surplus SLR is also being built to reduce the negative carry and ensure enough liquidity for repos and TLTRO transactions. The Bank is also exploring Securitization and IBPC transactions in addition to term loan facilities from banks and available lines of refinance from NABARD, SIDBI and NHB and medium term line of credit from these DFIs.